The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

chloroaluminum     chloroaluminum

Synonyms: AC1NSDY9, CHEBI:30131, FT-0622236, [AlCl], 13595-81-8, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of chloroaluminum

 

High impact information on chloroaluminum

  • METHODS AND RESULTS: Shortly after impregnation with the photosensitizer drug chloroaluminum sulfonated phthalocyanine, infrarenal aortas of ACI rats were PDT-treated and orthotopically grafted in Lewis rats (PDT) [6].
  • Chloroaluminum sulfonated phthalocyanine pharmacokinetics in tumor-bearing mice were measured using a fiber-based spectrofluorometer [7].
  • The K+/H+ ionophore nigericin dramatically increases killing of V79 cells and A549 cells by photodynamic therapy (PDT) sensitized by chloroaluminum phthalocyanine [8].
  • Photosensitized formation of ascorbate radicals by chloroaluminum phthalocyanine tetrasulfonate: an electron spin resonance study [9].
  • METHODS: PDT (5 to 200 J/cm2, 100 mW/cm2, 675 nm) was used with the photosensitizer chloroaluminum sulfonated phthalocyanine (5 micrograms/ml) to inactivate bFGF in vitro while 100 J/cm2 of irradiation was administered 24 hours after 5 mg/ml of the photosensitizer was used in vivo [10].
 

Biological context of chloroaluminum

 

Anatomical context of chloroaluminum

  • Photodynamic effects of chloroaluminum phthalocyanine tetrasulfonate are mediated by singlet oxygen: in vivo and in vitro studies utilizing hepatic microsomes as a model membrane source [15].
  • The interaction of chloroaluminum phthalocyanine-sensitized photodynamic treatment and gamma-irradiation was studied in confluent murine L929 fibroblasts [16].
  • The entire rat common carotid artery was balloon-injured to induce IH, whereas only the cervical segment below the bifurcation was subjected to PDT by external light irradiation after administration of the photosensitizer chloroaluminum sulfonated phthalocyanine [17].
  • The purpose of this study was to determine if recombinant angiogenic cytokines modulate the sensitivity of endothelial cells to the toxic effects of chloroaluminum sulphonated phthalocyanine (AlSPc) photodynamic therapy (PDT) [18].
  • In this work we used F- as a probe to evaluate the involvement of the plasma membrane functions of Chinese hamster ovary cells in photocytotoxicity induced by chloroaluminum phthalocyanine (AlPc) [19].
 

Associations of chloroaluminum with other chemical compounds

  • These species have been compared with respect to photogeneration rate on the one hand and susceptibility to enzymatic reduction/detoxification on the other, using the erythrocyte ghost as a cholesterol-containing test membrane and chloroaluminum phthalocyanine tetrasulfonate (AlPcS4) as a 1O2 sensitizer [20].
  • In in vitro studies, the HSCC cells showed a positive photodynamic response with Photofrin-II (Pf-II), chloroaluminum phthalocyanine tetrasulfonate (AlPcTS), and a newly synthesized silicon phthalocyanine (SiPc IV) [21].
 

Gene context of chloroaluminum

  • Mutagenic lesions at the thymidine kinase locus (tk) in mouse lymphoma L5178Y (LY) cells treated with red light and either Photofrin (PF) or chloroaluminum phthalocyanine (AlPc) as the photosensitizer were compared in the relatively photodynamic therapy (PDT)-sensitive strain LY-R16 and the relatively resistant strains LY-S1 and LY-SR1 [22].
  • We examined the effect of aspirin, a known inhibitor of both cyclooxygenase and platelet activity, on PDT using chloroaluminum sulfonated phthalocyanine (CASP) [23].
 

Analytical, diagnostic and therapeutic context of chloroaluminum

  • The photosensitizer chloroaluminum sulfonated phthalocyanine (5 mg/kg) for the experimental group or saline solution for the control group was administered intravenously [24].
  • New corneal vessels were irradiated with a diode laser (670 nm, 2 mW) after the intravenous injection of chloroaluminum sulfonated phthalocyanine [25].
  • A noninvasive in situ fluorescence-based method for the quantification of the photosensitizer chloroaluminum disulfonated phthalocyanine was compared to the highly accurate but nonreal time ex vivo spectrofluorometry method [26].

References

  1. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Agarwal, M.L., Clay, M.E., Harvey, E.J., Evans, H.H., Antunez, A.R., Oleinick, N.L. Cancer Res. (1991) [Pubmed]
  2. Photodynamic therapy of pigmented choroidal melanomas. Gonzalez, V.H., Hu, L.K., Theodossiadis, P.G., Flotte, T.J., Gragoudas, E.S., Young, L.H. Invest. Ophthalmol. Vis. Sci. (1995) [Pubmed]
  3. Chloroaluminum phthalocyanine tetrasulfonate delivered via acid-labile diplasmenylcholine-folate liposomes: intracellular localization and synergistic phototoxicity. Qualls, M.M., Thompson, D.H. Int. J. Cancer (2001) [Pubmed]
  4. Enhancement of Nile blue derivative-induced photocytotoxicity by nigericin and low cytoplasmic pH. Lin, C.W., Shulok, J.R. Photochem. Photobiol. (1994) [Pubmed]
  5. Effectiveness of corneal neovascularization photothrombosis using phthalocyanine and a diode laser (675 nm). Pallikaris, I.G., Tslimbaris, M.K., Iliaki, O.E., Naoumidi, I.I., Georgiades, A., Panagopoulos, I.A. Lasers in surgery and medicine. (1993) [Pubmed]
  6. Photodynamic therapy inhibits experimental allograft rejection. A novel approach for the development of vascular bioprostheses. LaMuraglia, G.M., Adili, F., Schmitz-Rixen, T., Michaud, N.A., Flotte, T.J. Circulation (1995) [Pubmed]
  7. Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake. Roberts, W.G., Hasan, T. Cancer Res. (1993) [Pubmed]
  8. Effect of the K+/H+ ionophore nigericin on response of A549 cells to photodynamic therapy and tert-butylhydroperoxide. Varnes, M.E., Bayne, M.T., Menegay, H.J., Tuttle, S.W. Free Radic. Biol. Med. (1993) [Pubmed]
  9. Photosensitized formation of ascorbate radicals by chloroaluminum phthalocyanine tetrasulfonate: an electron spin resonance study. Kim, H., Rosenthal, I., Kirschenbaum, L.J., Riesz, P. Free Radic. Biol. Med. (1992) [Pubmed]
  10. Photodynamic therapy inactivates extracellular matrix-basic fibroblast growth factor: insights to its effect on the vascular wall. LaMuraglia, G.M., Adili, F., Karp, S.J., Statius van Eps, R.G., Watkins, M.T. J. Vasc. Surg. (1997) [Pubmed]
  11. Effect of multidrug-resistant P-glycoprotein gene expression on chloroaluminum tetrasulfonate phthalocyanine concentration. Frazier, D.L., Barnhill, M.A., Lu, X., Jones, E., Niemeyer, G., Mishu, L., Lothrop, C.D. Lasers in surgery and medicine. (1993) [Pubmed]
  12. Initiation of apoptosis versus necrosis by photodynamic therapy with chloroaluminum phthalocyanine. Luo, Y., Kessel, D. Photochem. Photobiol. (1997) [Pubmed]
  13. Single strand breaks and mutagenesis in yeast induced by photodynamic treatment with chloroaluminum phthalocyanine. Paardekooper, M., De Bruijne, A.W., Van Gompel, A.E., Verhage, R.A., Averbeck, D., Dubbelman, T.M., Van den Broek, P.J. J. Photochem. Photobiol. B, Biol. (1997) [Pubmed]
  14. Involvement of singlet oxygen in chloroaluminum phthalocyanine tetrasulfonate-mediated photoenhancement of lipid peroxidation in rat epidermal microsomes. Agarwal, R., Athar, M., Urban, S.A., Bickers, D.R., Mukhtar, H. Cancer Lett. (1991) [Pubmed]
  15. Photodynamic effects of chloroaluminum phthalocyanine tetrasulfonate are mediated by singlet oxygen: in vivo and in vitro studies utilizing hepatic microsomes as a model membrane source. Agarwal, R., Zaidi, S.I., Athar, M., Bickers, D.R., Mukhtar, H. Arch. Biochem. Biophys. (1992) [Pubmed]
  16. Post-treatment interactions of photodynamic and radiation-induced cytotoxic lesions. Ramakrishnan, N., Clay, M.E., Friedman, L.R., Antunez, A.R., Oleinick, N.L. Photochem. Photobiol. (1990) [Pubmed]
  17. Importance of the treatment field for the application of vascular photodynamic therapy to inhibit intimal hyperplasia. Statius van Eps, R.G., ChandraSekar, N.R., Hasan, T., LaMuraglia, G.M. Photochem. Photobiol. (1998) [Pubmed]
  18. Cytokine modulation of endothelial cell sensitivity to photodynamic therapy. Breider, M.A., Lu, X., Panjehpour, M., Frazier, D.L. Lasers in surgery and medicine. (1993) [Pubmed]
  19. Effect of fluoride on inhibition of plasma membrane functions in Chinese hamster ovary cells photosensitized by aluminum phthalocyanine. Ben-Hur, E., Dubbelman, T.M., Van Steveninck, J. Radiat. Res. (1992) [Pubmed]
  20. Photodynamically generated 3-beta-hydroxy-5 alpha-cholest-6-ene-5- hydroperoxide: toxic reactivity in membranes and susceptibility to enzymatic detoxification. Geiger, P.G., Korytowski, W., Girotti, A.W. Photochem. Photobiol. (1995) [Pubmed]
  21. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice. Megerian, C.A., Zaidi, S.I., Sprecher, R.C., Setrakian, S., Stepnick, D.W., Oleinick, N.L., Mukhtar, H. Laryngoscope (1993) [Pubmed]
  22. Large mutagenic lesions are induced by photodynamic therapy in murine L5178Y lymphoblasts. Deahl, J.T., Oleinick, N.L., Evans, H.H. Photochem. Photobiol. (1993) [Pubmed]
  23. Effect of aspirin on photodynamic therapy utilizing chloroaluminum sulfonated phthalocyanine (CASP). Stern, S.J., Craig, J.R., Flock, S., Small, S. Lasers in surgery and medicine. (1992) [Pubmed]
  24. Photodynamic therapy inhibition of experimental intimal hyperplasia: acute and chronic effects. LaMuraglia, G.M., ChandraSekar, N.R., Flotte, T.J., Abbott, W.M., Michaud, N., Hasan, T. J. Vasc. Surg. (1994) [Pubmed]
  25. Phthalocyanine mediated photodynamic thrombosis of experimental corneal neovascularization: effect of phthalocyanine dose and irradiation onset time on vascular occlusion rate. Tsilimbaris, M.K., Pallikaris, I.G., Naoumidi, I.I., Vlahonikolis, I.G., Tsakalof, A.K., Lydataki, S.E. Lasers in surgery and medicine. (1994) [Pubmed]
  26. Comparison of photosensitizer (AIPcS2) quantification techniques: in situ fluorescence microsampling versus tissue chemical extraction. Lee, C.C., Pouge, B.W., Strawbridge, R.R., Moodie, K.L., Bartholomew, L.R., Burke, G.C., Hoopes, P.J. Photochem. Photobiol. (2001) [Pubmed]
 
WikiGenes - Universities